A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion
Galectin-3 is a sugar-binding protein that can inhibit antitumour cytotoxic immunity. Here the authors show that Galectin-3 expressed by tumour cells inhibits LFA-1 on cytotoxic lymphocytes, impairing immunological synapse formation, IFNg secretion, and target cell killing.
Guardado en:
Autores principales: | Anne-Elisabeth Petit, Nathalie Demotte, Benoît Scheid, Claude Wildmann, René Bigirimana, Monica Gordon-Alonso, Javier Carrasco, Salvatore Valitutti, Danièle Godelaine, Pierre van der Bruggen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3477da4108d44f4daa43367177312336 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration
por: Monica Gordon-Alonso, et al.
Publicado: (2017) -
Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse
por: Roxana Khazen, et al.
Publicado: (2016) -
New insights to the functional role of the T cell-Antigen Presenting Cell immunological synapse
por: FAROUDI,MUSTAPHA, et al.
Publicado: (2002) -
Galectin-8 binds to LFA-1, blocks its interaction with ICAM-1 and is counteracted by anti-Gal-8 autoantibodies isolated from lupus patients
por: Vicuña,Lucas, et al.
Publicado: (2013) -
Role of LFA-1 integrin in the control of a lymphocytic choriomeningitis virus (LCMV) infection
por: Mario Perro, et al.
Publicado: (2020)